By analyzing the TCGA database and performing HR repair screening, we demonstrated that three BRD-containing proteins, BRD9, ASH1L, and ZMYND8, positively regulate HR, and the mutations of these three BRD-containing proteins are associated with HR-deficient mutational signatures in ovarian cancer. Here, BRD9 is linked to ovarian carcinoma.